Promore – Reports and prospectus

Annual Reports (Promore) May 9, 2023 Årsredovisning 2022	Report (pdf)
Annual Reports (Promore) May 9, 2023 Annual Report 2022	Report (pdf)
Annual Reports (Promore) April 26, 2022 Årsredovisning 2021	Report (pdf)
Annual Reports (Promore) April 26, 2022 Annual Report 2021	Report (pdf)
Annual Reports (Promore) May 6, 2021 Årsredovisning 2020	Report (pdf)
Annual Reports (Promore) May 6, 2021 Annual Report 2020	Report (pdf)
Annual Reports (Promore) May 5, 2020 Årsredovisning 2019	Report (pdf)
Annual Reports (Promore) May 5, 2020 Annual Report 2019	Report (pdf)
Annual Reports (Promore) April 30, 2019 Årsredovisning 2018	Report (pdf)
Annual Reports (Promore) April 30, 2019 Annual Report 2018	Report (pdf)
Annual Reports (Promore) April 25, 2018 Årsredovisning 2017	Report (pdf)
Annual Reports (Promore) April 25, 2018 Annual Report 2017	Report (pdf)
Annual Reports (Promore) May 17, 2017 Årsredovisning Juli 2015 – December 2016	Report (pdf)
Annual Reports (Promore) May 17, 2017 Annual Report July 2015 – December 2016	Report (pdf)
Annual Reports (Promore) April 25, 2017 Pergamum AB – Årsredovisning Juli 2015 – December 2016	Report (pdf)
Annual Reports (Promore) April 25, 2017 Pergamum AB – Annual Report July 2015 – December 2016	Report (pdf)
Annual Reports (Promore) January 29, 2016 Pergamum AB – Årsredovisning 20140701 – 20150630	Report (pdf)
Annual Reports (Promore) January 29, 2016 Pergamum AB – Annual Report 20140701 – 20150630	Report (pdf)
Annual Reports (Promore) December 17, 2015 Lipopeptide AB - Årsredovisning 20140701–20150630	Report (pdf)
Annual Reports (Promore) December 17, 2015 Lipopeptide AB - Annual Report 20140701–20150630	Report (pdf)

MESSAGE FROM THE CEO

Read what our CEO has to say about our business.

Read the CEO message

BUSINESS MODEL

The RespiraSense™ business model consists of several components that together create a complete delivery that generates attractive gross margins and recurring revenues.

Learn more about the business model

VISION

To avoid preventable respiratory failure events by transforming the standard of care in patient monitoring.

MISSION

To become the de facto standard-of-care for monitoring respiratory compromised patients in Europe and the US.